PETALING JAYA: Apex Healthcare Bhd
will be officially delisted on Jan 27, following the completion of Pharmora Investment Holdings Pte Ltd’s takeover and privatisation of the company.
In a filing with Bursa Malaysia, the pharmaceutical group said it will be removed from the official list of Bursa Malaysia Securities Bhd effective 9am on Tuesday.
It was announced earlier this month that Pharmora and persons acting in concert secured a 95.43% stake in Apex Healthcare.
The stake had exceeded the requisite 90% threshold to delist the pharmaceutical group from Bursa Malaysia.
The offer became unconditional after crossing the 90% mark on Dec 22, which was subsequently extended to Jan 5 to facilitate further acceptances.
Trading in Apex Healthcare shares was suspended on Jan 13, in line with Bursa Malaysia’s requirements pending the delisting process.
Pharmora is a special-purpose vehicle jointly held by Quadria Capital Fund III Holdings Pte Ltd and Dr Kee Kirk Chin, who is also Apex Healthcare’s major shareholder, chairman and chief executive officer.
